First targeted treatment to reduce the risk of ALK positive lung cancer returning after complete tumour removal recommended ...

The new modifier was introduced in 2022 to allow extra weight to be given to medicines that address severe diseases. It ...

Demand for NHS Talking Therapies has reached an all-time high. The service received 1.82 million referrals in 2023/24. This is slightly higher than 2021/2022, and more than double the 884,000 received ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

All NICE products on people with learning disabilities. Includes any guidance and quality standards.

Delirium is a sudden change in a person’s mental state. It is a serious condition that is sometimes mistaken for dementia or, more rarely, depression. Unlike dementia, delirium develops quickly and is ...

For the first time, NICE has recommended a targeted treatment option for ALK-positive non-small-cell lung cancer, to be given after surgery to reduce the risk of the disease coming back. Today (1 ...

All NICE products on personality disorders. Includes any guidance and quality standards.

Guidance that can help you make cost savings and find efficiencies in your local services. Includes impact reports and templates that allow you to accurately estimate savings for your local setting. A ...

socioeconomic status and deprivation sharing certain protected characteristics belonging to vulnerable or excluded groups of society geography. These factors often overlap, meaning people can fall ...

You can access a range of bibliographical databases with your NHS OpenAthens account. Sign in to see what you can access. You can access bibliographic databases from the providers' websites. For ...

All NICE products on physical activity. Includes any guidance and quality standards.